Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.

Autor: Galindo-Feria AS; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.; Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden., Lodin K; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.; Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden., Horuluoglu B; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden., Sarrafzadeh-Zargar S; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden., Wigren E; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Structural Genomics Consortium, Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Gräslund S; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Structural Genomics Consortium, Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Danielsson O; Division of Neurology, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linkoping University, Linkoping, Sweden., Wahren-Herlenius M; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Norway., Dastmalchi M; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.; Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden., Lundberg IE; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.; Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Jun 04. Date of Electronic Publication: 2024 Jun 04.